Aspen sees Mounjaro Africa sales above $124 million in 2027

Aspen Pharmacare projects African sales of Eli Lilly’s Mounjaro to exceed 2 billion rand ($124 million) in the current financial year, driven by strong South Africa demand and planned launches in Nigeria and Kenya. The outlook is supportive of growth momentum for the distribution/launch pipeline, with the company signaling a material revenue contribution from the product in the region.